Aligning cancer quality metrics across the continuum of community-based and academic medicine using a prioritization tool. This is an ASCO Meeting Abstract from the 2012 Quality Care Symposium. This ...

The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...

Mutation testing is a fault-based software validation technique that involves introducing small, systematic changes (or “mutants”) into programme code to assess the capability of test suites in ...

Mutational profiles of lung adenocarcinoma subtypes. Association of HLA class 1 homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with PD-1 ...

PROVIDENCE, R.I. [Brown University] -- Tests that can distinguish whether HIV-positive people are infected with a drug-resistant strain or a non-resistant strain allow patients to get the most ...

Previously, it was recommended for women who have a family history of breast, ovarian, tubal or peritoneal cancer to be assessed for harmful BRCA1 or BRCA2 mutations. That recommendation was last made ...

Testing for breast cancer and other diseases caused by BRCA1 and BRCA2 genetic mutations becomes easier now that the U.S. Federal Drug Administration has approved 23andMe's genetic test. The test kit ...

Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.